Abstract
We have investigated electrolyte exchange in myasthenia gravis before and after corticotrophin therapy, using a four-isotope dilution technique. Clinical deterioration in patients on corticotrophin is associated with a fall of more than 20% in the intracellular potassium concentration, suggesting that all myasthenics so treated should be given potassium supplementation.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DAHLBACK O., ELMQVIST D., JOHNS T. R., RADNER S., THESLEFF S. An electrophysiologic study of the neuromuscular junction in myasthenia gravis. J Physiol. 1961 Apr;156:336–343. doi: 10.1113/jphysiol.1961.sp006679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liversedge L. A., Yuill G. M., Wilkinson I. M., Hughes J. A. Benefit from adrenocorticotrophin in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):412–415. doi: 10.1136/jnnp.37.4.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
